[Behavior of adrenocorticotropic internal secretions in Cushing's syndrome].
D015065:17-Hydroxycorticosteroids / Q000097:blood* / Q000652:urine; D000307:Adrenal Gland Diseases / Q000150:complications; D000324:Adrenocorticotropic Hormone / Q000097:blood; D002940:Circadian Rhythm; D003480:Cushing Syndrome / Q000097:blood / Q000209:etiology / Q000378:metabolism* / Q000652:urine; D003907:Dexamethasone; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006965:Hyperplasia; D007328:Insulin; D008797:Metyrapone; D010912:Pituitary-Adrenal Function Tests; D011749:Pyrogens; D014667:Vasopressins
D015065:17-Hydroxycorticosteroids; D007328:Insulin; D011749:Pyrogens; D014667:Vasopressins; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone; D008797:Metyrapone
Verhalten der adrenokortikotropen Inkretion beim Cushing-Syndrom.